Thermo Fisher Scientific Inc.TMO
NYSE•Healthcare•Diagnostics & Research
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $45.20B, growing 5.4% year-over-year. TTM net income stood at $6.85B (5.1% growth). Quarterly EBITDA was $2.17B and operating income was $1.86B. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze TMO growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters